Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04809714 · ClinicalTrials.gov registry record · NA
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
A NA study of Hip Fractures and Muscle Atrophy, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04809714: Active NA study of Hip Fractures and Muscle Atrophy, sponsored by University of Alabama at Birmingham.
NCT04809714 is a NA study of Hip Fractures and Muscle Atrophy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 620-participant average among 15 other Hip Fractures trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04809714, a NA study of Hip Fractures and Muscle Atrophy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to study the use of blood flow restriction therapy (BFR) to augment routine post-operative physical therapy in elderly patients (age \>= 65) after recovering from surgical treatment of hip fractures.
Primary Outcome
10cm proximal to superior pole patella and leg circumference measured at 10 distal to inferior pole patella for both extremities
Conditions Studied
Interventions
- DEVICE Blood Flow Restriction with Delfi Tourniquet System Cuff
- OTHER Routine Post-operative Physical Therapy
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT04809714 still lists
NCT04809714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 620-participant average among 15 other Hip Fractures trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which Blood Flow Restriction with Delfi Tourniquet System Cuff is the first listed.
NCT04809714 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04809714 about?
NCT04809714 is a clinical study titled "The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture". The investigators aim to study the use of blood flow restriction therapy (BFR) to augment routine post-operative physical therapy in elderly patients (age \>= 65) after recovering from surgical treatment of hip fractures.
What is the current status of trial NCT04809714?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04809714 study?
This clinical trial studies the following conditions: Hip Fractures, Muscle Atrophy.
What interventions are being tested in trial NCT04809714?
The interventions under investigation include: Blood Flow Restriction with Delfi Tourniquet System Cuff (DEVICE), Routine Post-operative Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT04809714?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04809714 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04809714's enrollment target sits among peer trials
20 16th of 15 the lowest of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING · NA
-
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI